These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26517134)

  • 1. Application of iChip to Grow "Uncultivable" Microorganisms and its Impact on Antibiotic Discovery.
    Sherpa RT; Reese CJ; Montazeri Aliabadi H
    J Pharm Pharm Sci; 2015; 18(3):303-15. PubMed ID: 26517134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teixobactin, the first of a new class of antibiotics discovered by iChip technology?
    Piddock LJ
    J Antimicrob Chemother; 2015 Oct; 70(10):2679-80. PubMed ID: 26089440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient total syntheses and biological activities of two teixobactin analogues.
    Parmar A; Iyer A; Vincent CS; Van Lysebetten D; Prior SH; Madder A; Taylor EJ; Singh I
    Chem Commun (Camb); 2016 Apr; 52(36):6060-3. PubMed ID: 26984316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teixobactin and Its Analogues: A New Hope in Antibiotic Discovery.
    Fiers WD; Craighead M; Singh I
    ACS Infect Dis; 2017 Oct; 3(10):688-690. PubMed ID: 28770988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of teixobactin.
    Karas JA; Chen F; Schneider-Futschik EK; Kang Z; Hussein M; Swarbrick J; Hoyer D; Giltrap AM; Payne RJ; Li J; Velkov T
    Ann N Y Acad Sci; 2020 Jan; 1459(1):86-105. PubMed ID: 31792983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic discovery: combining isolation chip (iChip) technology and co-culture technique.
    Lodhi AF; Zhang Y; Adil M; Deng Y
    Appl Microbiol Biotechnol; 2018 Sep; 102(17):7333-7341. PubMed ID: 29974183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teixobactins: a new class of 21st century antibiotics to combat multidrug-resistant bacterial pathogens.
    Iyer A; Madder A; Singh I
    Future Microbiol; 2019 Apr; 14():457-460. PubMed ID: 31033354
    [No Abstract]   [Full Text] [Related]  

  • 8. Rational Design and Synthesis of Modified Teixobactin Analogues: In Vitro Antibacterial Activity against Staphylococcus aureus, Propionibacterium acnes and Pseudomonas aeruginosa.
    Ng V; Kuehne SA; Chan WC
    Chemistry; 2018 Jun; 24(36):9136-9147. PubMed ID: 29741277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creative targeting of the Gram-negative outer membrane in antibiotic discovery.
    MacNair CR; Tsai CN; Brown ED
    Ann N Y Acad Sci; 2020 Jan; 1459(1):69-85. PubMed ID: 31762048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of novel teixobactin analogues.
    Schumacher CE; Harris PWR; Ding XB; Krause B; Wright TH; Cook GM; Furkert DP; Brimble MA
    Org Biomol Chem; 2017 Oct; 15(41):8755-8760. PubMed ID: 28993827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of backbone N-methylation on the structure-activity relationship of Leu
    Velkov T; Swarbrick JD; Hussein MH; Schneider-Futschik EK; Hoyer D; Li J; Karas JA
    J Pept Sci; 2019 Sep; 25(9):e3206. PubMed ID: 31389086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antibacterial studies of teixobactin analogues with non-isostere substitution of enduracididine.
    Jin K; Po KHL; Kong WY; Lo CH; Lo CW; Lam HY; Sirinimal A; Reuven JA; Chen S; Li X
    Bioorg Med Chem; 2018 Mar; 26(5):1062-1068. PubMed ID: 29398444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery, synthesis, and optimization of teixobactin, a novel antibiotic without detectable bacterial resistance.
    Qi YK; Tang X; Wei NN; Pang CJ; Du SS; Wang K
    J Pept Sci; 2022 Nov; 28(11):e3428. PubMed ID: 35610021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new antibiotic kills pathogens without detectable resistance.
    Ling LL; Schneider T; Peoples AJ; Spoering AL; Engels I; Conlon BP; Mueller A; Schäberle TF; Hughes DE; Epstein S; Jones M; Lazarides L; Steadman VA; Cohen DR; Felix CR; Fetterman KA; Millett WP; Nitti AG; Zullo AM; Chen C; Lewis K
    Nature; 2015 Jan; 517(7535):455-9. PubMed ID: 25561178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic evaluation of the secondary metabolism of antistaphylococcal environmental bacterial isolates.
    Wyatt MA; Lee J; Ahilan Y; Magarvey NA
    Can J Microbiol; 2013 Jul; 59(7):465-71. PubMed ID: 23826955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gram-scale total synthesis of teixobactin promoting binding mode study and discovery of more potent antibiotics.
    Zong Y; Fang F; Meyer KJ; Wang L; Ni Z; Gao H; Lewis K; Zhang J; Rao Y
    Nat Commun; 2019 Jul; 10(1):3268. PubMed ID: 31332172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic Adjuvants: Rescuing Antibiotics from Resistance.
    Wright GD
    Trends Microbiol; 2016 Nov; 24(11):862-871. PubMed ID: 27430191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenge of antimicrobial resistance: new regulatory tools to support product development.
    Tomayko JF; Rex JH; Tenero DM; Goldberger M; Eisenstein BI
    Clin Pharmacol Ther; 2014 Aug; 96(2):166-8. PubMed ID: 24823890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Fluorescent Teixobactin Analogue.
    Morris MA; Malek M; Hashemian MH; Nguyen BT; Manuse S; Lewis K; Nowick JS
    ACS Chem Biol; 2020 May; 15(5):1222-1231. PubMed ID: 32045203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of extracts of algae from Baja California sur, Mexico as reversers of the antibiotic resistance of some pathogenic bacteria.
    Muñoz-Ochoa M; Murillo-Alvarez JI; Zermeño-Cervantes LA; Martínez-Diaz S; Rodríguez-Riosmena R
    Eur Rev Med Pharmacol Sci; 2010 Sep; 14(9):739-47. PubMed ID: 21061832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.